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Introduction
　Signal transduction pathways are important for 
understanding homeostatic mechanisms and specific 
reactions1)－3). Many molecular mechanisms related to 
signal transduction pathways have been identified 
and are leading to the development of many useful 
medicines. Although the schema of these pathways is 
useful for understanding the specific hierarchical 
pathways, it is dificult to recognize concurrently 
activated signals and growing factors in one schema. 
Recently, new methodologies, such as various 
comprehensive analyses (proteome, metabolome, or 
genome) and computational studies, have been 
developed to investigate various hyper-complex 
systems in life sciences4)－7). These analyses identified 
numerous molecules that help in diferentiating 
samples. However, growing factors identified by these 
high-dimensional approaches cannot always lead to 
discovery of a causal relationship in signal transduc-
tion pathways. Specificaly, a comparison of the 
average molecular amount in cel lysis samples cannot 
easily clarify the pathways in heterogeneous cels and 
asynchronously activated cels8), 9). Furthermore, the 
pathways are spatio-temporaly regulated by feedback 
mechanisms, protein modification mechanisms, or 
cel-to-cel communication7), 10). Thus, discovering the 
direct cause among the growing factors is very 
dificult.
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　Investigation of signal transduction mechanisms is important for development of therapy and 
understanding complex life systems. In this study, to establish a novel recognition method of signal 
transduction pathways, we investigated signal transducers using flow cytometry.
　The flow cytometric measurement shows a mean phosphorylation level (mean of fluorescence 
intensity, MFI) and a deviation of the phosphorylation level (coeficient variation, CV) in a cluster of 
cels. As a model of signal pathways, Jurkat cels (T cel leukemia cel line) were stimulated with 
interleukin-21 or interferon-α, and signal transducers and activators of transcription (STATs) and 
extracelular signal-regulated kinase (ERK) 1/2 were measured using flow cytometry. Furthermore, 
peripheral blood was stimulated, and then various signal transducers of the lymphocytes and 
neutrophils were analyzed with MFI and CV.
　After the stimulation, the increase of STATs MFI induced a temporal change of CV. On the other 
hand, the decrease of ERK1/2 phosphorylation accompanied the sustained increase of CV. Finaly, we 
classified the signaling characters into five types using a combination of MFI and CV. These findings 
contribute to an explanation of the known relationship between signal transducers and stimulants on 
each cel subset. Therefore, this method may be useful to discover a causal relationship between 
stimulants and signal transducers in complex systems.





　In this study, we analyzed signal transducers and 
activators of transcription (STATs) and extracelular 
signal-regulated kinase (ERK) 1/2 in the Jurkat cel 
line as a model of cel signaling. STATs are known to 
be activated in a receptor-specific manner11). For 
example, STAT1 is activated by stimulation from 
interferon-α (IFN-α)12), 13), and STAT3 is activated 
by stimulation from interleukin (IL)-2114), 15). ERK1/2 
(MAP kinase family) is a known regulator of celular 
proliferation16), 17). Furthermore, the ERK1/2 pathway 
is subsequently activated by various stimulations 
such as lipopolysaccharide and redox status18), 19).
　Phospho-specific flow cytometry for signal network-
ing has several advantages, such as single cel analysis 
capability, multi-parameter data acquisition, rapid 
protocols, and the ability to analyze rare cel subsets, 
compared with traditional biochemical methods20). 
Recently, the analysis methods of flow cytometry 
have been combined with various comprehensive 
analyses21), 22). However, a percentage of positive cels 
or a value of mean of fluorescence intensity (MFI) 
have been used for these flow cytometric analyses. In 
this study, we postulated a theoretical method of 
signaling recognition in complex systems and applied 
the theory to analysis of signal transduction using 
coeficient variation (CV). We demonstrated the 
validity of a novel recognition method using flow 
cytometry and classification of STATs, ERK1/2, etc., 
as contractive or fluctuating signals. This novel 
method wil alow the use of bioinformatics to 
discover a causal relationship between stimulants and 
signal pathways in complex systems.
Materials and Methods
Jurkat cels
　Jurkat cels were obtained from the Department of 
Immunology at Tohoku University School of Medicine 
(originaly gifted from Ajinomoto Co. Ltd, Tokyo) and 
maintained in RPMI 1640 (Sigma-Aldrich, St. Louis, 
MO, USA) supplemented with 10% fetal calf serum 
(Biowest, Nuailé, France), 50 U/mL penicilin G 
potassium, and 50 µg/mL streptomycin sulfate at 
37˚C in 5% CO2 with high humidity. 
Peripheral blood
　This study was approved by the Ethics Committee 
of Yamagata University Faculty of Medicine (approval 
number, 265). Peripheral blood was colected from 
healthy volunteers folowing informed consent and 
heparinized by 5 U/mL of low molecular weight 
heparin. The average age of the donors was 49.3 ± 2.6 
years (n = 4). Folowing sample colection, the blood 
was immediately transferred into 1.5 mL microtubes 
and used for experiments. 
Cel stimulation with cytokines
　Cel stimulation was performed as previously 
reported 23). Briefly, Jurkat cels (0.7 to 1 x 106 
cels/mL, 0.5 mL/tube) or whole peripheral blood cels 
(0.1 mL/tube) were stimulated with IFN-α (Takeda 
Pharmaceutical Co. Ltd, Osaka, Japan) or IL-21 
(Peprotech, Rocky Hil, NJ, USA) for 10 to 90 min in 
microtubes at 37°C. In several experiments, the cels 
were preincubated with MEK1/2 inhibitor (U0126, 
Thermo Fisher Scientific, Waltham, MA, USA) for 10 
min at 37˚C. After the stimulation, the cels were 
immediately fixed by Lyse/Fix bufer (BD Biosciences, 
San Jose, CA, USA) for 10 min at 37°C. The fixed cels 
were packed by centrifugation at 800 x g for 1 min 
and then stocked in 90% methanol (0.3 mL/tube) at 
－20°C until flow cytometric analysis.
Flow cytometric analysis
　The fixed cels were washed with 0.8 mL phosphate-
bufered saline (PBS) and suspended in PBS 
containing 1% bovine serum albumin and 0.1% 
sodium azide. The cels were transferred into 
V-bottom 96-wel plates and were incubated with 
each antibody for 45 min at 22-25°C. The antibodies 
used in this study are summarized in Table 123). After 
the reaction, the cels were washed with PBS and 
measured by flow cytometry (ec800, Sony, Tokyo, 
Japan; FACSCanto II, BD Biosciences, Franklin 
Lakes, NJ, USA). Debris was excluded from the 
analysis by dim-forward and side-scatter gating. The 
fluorescence intensity and robust coeficient value 
(CV) were analyzed using FlowJo software (v6.2, 
TreeStar, Ashland, OR, USA). The calculation 
formula for robust CV is as folows: CV = 100 × 1/2 
[(Intensity at 84.13 percentile) –(Intensity at 15.87 
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percentile)] / Median. This calculation is not afected 
by the number of cel events.
Statistical analysis
　Comparison between each data set was performed 
by one-way or two-way analysis of variance with a 
post hoc Bonferroni test. A two group comparison was 
performed with a paired t-test. Correlation was 
calculated with the Pearson R test. Data analysis was 
performed using Prism Software (v5.03, GraphPad 
Software, San Diego, CA, USA). P values less than 
0.05 were considered significant. A bubble chart 





Theoretical recognition of biological systems
　Statuses of components (cels, signal transducers, 
or metabolites) in biological systems continuously 
fluctuate and are gradualy drawn to attractants. The 
fluctuation and attraction are repeated, and the 
itinerant history of the attracted components decides 
the fate of biological responses24). This premise alows 
us to speculate as folows: When stimulation induces 
change of status, the representative change of status, 
i.e., observable action, can be discovered in the upper 
layer (Fig. 1A). In the lower layer, fluctuation and 
contraction of status simultaneously occur as 
undetectable actions (Fig. 1A). Furthermore, fluctua-
tion is required to change the status prior to 
attraction to the representative action. Therefore, 
undetectable action in the lower layer consists of 
fluctuation and contraction of status.
　From another point of view, statuses of components 
in biological systems are expressed by multi-paramet-
ric coordinates (Fig. 1B). For example, the status of a 
single cel is expressed as a dot (shown as a blue 
bubble in Fig. 1B) on the coordinate, so that the 
cluster of these cels is presented as a cluster of dots, 
which is similar to results obtained by flow cytometry 
analysis. As described above (Fig. 1A), the status of 
the cluster is changed to contraction from fluctuation 
by stimulation. Therefore, contraction of the dots 
indicates attraction, and divergence of the dots shows 
fluctuation. The contracted status is transited 
(recognized as a representative response) to the upper 
layer on another multi-parametric coordinate. Kinetic 
projection indicates the process of attraction to 
contractive status, such as time course, calcium 
influx, phosphorylation of signal transducers, etc. 
Thus, the changing status of cel clusters wil also 
show the contraction or fluctuation on a multi-
parametric coordinate.
Utilization of CV and MFI to examine biological 
responses
　The status of components in biological systems is 
expressed by coordinates, and the status of clusters is 
projected on a planar view of simple parameters as 
shown in Fig. 1B. MFI is wel used for the analysis 
using flow cytometry. However, MFI is not suitable for 
detection of contraction or fluctuation of biological 
responses, since MFI is value of average of the events. 
In this study, we propose to use CV to analyze 
contraction or fluctuation of the events.
　To understand the utilization of CV and MFI in 
biological responses, a schema of a single parametric 
phase of biological responses is shown in Fig. 2. The 
blue bubbles indicate single cels, and the red arrows 
show kinetic direction of cels after stimulation. 
Table 1. List of antibodies used in this study
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Dotted blue arrows indicate stochastic cel position or 
kinetic energy of cels before and after stimulation. 
The range of stochastic cel positions is applied to CV. 
Kinetic energy, i.e., the speed of fluctuating cels, to 
overcome the attractor (or another fluctuation) is 
related to MFI. Before initiation of attraction, both 
MFI and CV increase, and when cels enter the 
attraction (action), CV decreases and MFI increases. 
Experimental section
Verification of MFI and CV during stimulation
　To verify this hypothesis, Jurkat cels were 
stimulated with IFN-α or IL-21, and then the 
phosphorylated signal transducers were stained with 
each specific antibody. Finaly, these cels were 
measured by flow cytometry. The fluctuations of cel 
clusters are detected as the CV of cel histograms, and 
the kinetic energy is considered as MFI. Representa-
tive analysis of flow cytometry is presented in Fig. 3. 
In this study, CV was calculated as robust CV, which is 
not afected by cel count (total event numbers). MFI 
was calculated as the average of the sums of 
fluorescence of a single cel. Although the MFI results 
are already known results, the CV results are 
completely new data.
　CV, i.e., cel fluctuation, should be increased during 
stimulation, and the decrease of CV should be 
observed after the initiation of attraction, i.e., action 
(Fig. 2). The time course (time kinetics) observations 
help to understand the relationship between CV and 
kinetics of signal transducers (Fig. 4). As shown in the 
%change of MFI (Fig. 4, left-hand side panels), which 
indicates kinetics of signal activation, IFN-α 
temporaly induced the phosphorylation of STAT1 
(pSTAT1), and IL-21 also induced the temporal 
phosphorylation of STAT3 (pSTAT3) from 10 to 30 
min folowing treatment. After 30 min, the 
phosphorylation of STAT1 and STAT3 decreased. On 
the other hand, %change of MFI in pERK1/2 and 
pSTAT5 were not significantly changed by the 
stimulations. The change patterns (increase and 
Figure 1. Relationship between hierarchy of phenomena 
and transition of fluctuation to contraction.
 (A) Image schema of itinerant history of biological 
responses. The bubbles indicate components (cels, 
signal transducers, or metabolites), and the circles 
indicate clusters of these components in a biological 
system. The colors indicate change of status. The size of 
the circle represents contraction and fluctuation.
(B) Representation of biological response on multi-
parametric coordinates. The smal blue bubbles are the 
components in the biological system. The light blue 
areas are clusters of bubbles. The gray geometries show 
simple parameters on multi-parametric coordinates.
Figure 2. A schema of a single parametric phase of 
biological responses using coefficient variation (CV) and 
mean of fluorescence intensity (MFI).
Utilization of CV and MFI from flow cytometry analysis 
for schema of biological responses on a single parametric 
phase. Blue bubbles indicate single cels. Red arrows 
indicate cel movement after stimulation. Dotted blue 
arrows indicate stochastic cel position or cel movement 
before and after stimulation. The range of stochastic cel 
position is applied to CV. The energy (or speed of cel 
movement) to overcome initial attraction or another 
fluctuation is related to MFI. 
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decrease) of CV of each signal transducer were similar 
to %change of MFI (Fig. 4, right-hand side panels). 
Therefore, specific activations of signal transducers 
were observed with both MFI and CV. Interestingly, 
%change of MFI on pSTAT1 at 90 min was 
significantly augmented by stimulation with IFN-α 
compared with that of the vehicle at 90 min. However, 
CV was decreased (contractive) at 90 min. This 
contraction of CV and increase of MFI at 90 min were 
considered as the time of entrance into attraction. 
Thus, these results suggested that the change of MFI 
and CV was suitable for testing our hypothesis.
　To validate the relationship between the change of 
CV and dose of stimulants, the cels were stimulated 
with various doses of IFN-α (Fig. 5A and 5B) or IL-
21 (Fig. 5C and 5D). There was no discrepancy 
pattern between %change of MFI (Fig. 5A and 5C) 
and CV (Fig. 5B and 5D) at 10 and 30 min 
stimulations (before contraction). These results 
suggested that fluctuation (increase of CV) was not 
only augmented by low dose stimulations, but also by 
higher dose stimulations. 
　Finaly, correlation of CV to %change of MFI 
(change ratio from the initial MFI at 0 min) at 10 and 
30 min stimulations (Fig. 6A and 6B) and level of MFI 
(Fig. 6C and 6D) were analyzed. Although %change of 
MFI was significantly correlated with CV, the levels of 
MFI were not correlated with CV. These results 
suggested that the initial states of MFI at 0 min were 
not correlated with CV at 0 min; furthermore, the 
attracted state of MFI at 90 min was also not 
correlated with CV at 90 min. These discrepancies at 
initiation and attraction points strongly suggest that 
fluctuating CV and contractive CV changed independ-
ently of MFI during stimulation. These observations 
also indicated that the change of MFI and CV was 
suitable for testing our hypothesis.
Patern of CV change during decrease of MFI
　The ERK1/2 pathway is observed as oscilation and 
fluctuation. The pathway is activated in discrete, 
asynchronous pulses with frequency and duration 
determined by extracelular concentrations of 
stimulant 9). Furthermore, the frequency of pulse 
Figure 3. Representative analysis of coefficient variation (CV) and mean of fluorescence intensity (MFI) using 
histograms of phosphorylated signal transducers. Jurkat cels were stimulated with vehicle, IFN-α (100 U/mL), or 
IL-21 (1 nM) for 10 min. The representative overlay histograms of phosphorylated signal transducers, such as 
pSTAT1, pSTAT3, pSTAT5, and pERK1/2, are shown (blue shading = vehicle; red line = IFN-α or IL-21 
stimulation). Representative analysis of CV is shown in the upper left histogram panel. The CV was calculated as 
described in Materials and Methods.
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determines the signal characteristics25). In this study, 
we found that ERK1/2 fluctuation was induced by 
stimulation with IFN-α or IL-21 (Fig. 7). These 
stimulants significantly increased ERK1/2 (pERK1/2) 
CV (Fig. 7B), which accompanied the decrease of 
pERK1/2 MFI (Fig. 7A). In contrast to STATs CV, 
pERK1/2 CV, as shown in Fig. 7C, was inversely 
correlated with pERK1/2 MFI at al time point. 
Therefore, the stimulation might reduce activating 
frequency and result in an increase of CV.
　To clarify the inverse correlation between pERK1/2 
MFI and CV, we examined another condition to 
reduce the ERK1/2 activation. As shown in Fig. 8A, 
lower temperature (4°C) significantly reduced 
pERK1/2 MFI compared with normal conditions (37 
°C). Although not significant, an increase of pERK1/2 
CV was observed. Importantly, lower temperature 
was not suficient stimulation to increase CV; 
however, an inverse correlation between pERK1/2 
MFI and CV was observed. We also examined U0126 
as an inhibitor of MEK1/2, which are upstream of 
ERK1/2 activation (Fig. 8B). Similarly, U0126 
significantly reduced pERK1/2 MFI, and an inverse 
correlation between pERK1/2 MFI and CV was 
observed. These observations indicated that reduction 
of the ERK1/2 activating frequency induces the 
increase of pERK1/2 CV. Conversely, the reduction of 
pERK1/2 CV suggests that the pERK1/2 pathway 
synchronizes the oscilation and/or increases the 
frequency of the activation. 
 
Figure 4. Change of mean of fluorescence intensity 
(MFI) and coefficient variation (CV) after the addition of 
IFN-α or IL-21.
Jurkat cels were incubated with vehicle (open circle), 
IFN-α (closed circle, 100 U/mL), or IL-21 (closed 
triangle, 1 nM) for 0, 10, 30, and 90 min. After the 
incubation, the cels were fixed and analyzed by flow 
cytometry. The cels were stained with each antibody to 
detect pERK1/2 (A and B), pSTAT1 (C and D), pSTAT3 
(E and F), and pSTAT5 (G and H). Left-hand side panels 
(A, C, E, and G) show %change of MFI, calculated as 
folows: %change of MFI = 100 × [(MFI of cytokine at 
incubation time) – (MFI of vehicle at 10 min 
incubation)] / (MFI of vehicle at 10 min incubation). 
Right-hand side panels (B, D, E, and G) indicate CV. 
Data are mean ± SE, n = 4. The comparisons between 0 
min and each time point were performed using two-way 
ANOVA with Bonferroni’s post hoc test. Asterisks 
denote significant differences vs. vehicle (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001). 
Figure 5. Effect of cytokine doses on %change of MFI 
and CV.
Jurkat cels were activated by various doses of cytokines 
for 10 min (open circle) or 30 min (closed circle). The 
doses of IFN-α (A and B) were 0, 33, 100, and 300 
U/mL, and the doses of IL-21 (C and D) were 0.33, 1, and 
3 nM. Left-hand side panels (A and C) show %change of 
MFI, and right-hand side panels (B and D) show CV. 
Data are mean ± SE, n = 4.
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Multi-parametric presentation of signal pathways 
using bubble charts
　To facilitate the visualization of fluctuation and 
contraction of signal transducers, we presented the 
IFN-α- and IL-21-induced signaling kinetics, fluctua-
tion of ERK1/2, and specific reactions of STATs on 
two-dimensional bubble charts. As shown in Fig. 9, 
each bubble is one sample of cel clusters. The color of 
the bubble indicates the time course kinetics, and the 
bubble diameter represents pERK1/2 CV. The x-axis 
and y-axis on each panel represent pSTAT1, 3, or 5. 
As indicated by arrows, the specific reactions to each 
stimulant are observed through the transition from 
fluctuation (blue bubbles to red bubbles) to 
contraction (yelow bubbles to green bubbles). The 
increase of pERK fluctuation by stimulation is 
detected by the comparison between blue bubble size 
and green bubble size. For example, when the cels 
were stimulated with IL-21, red and yelow bubble 
density decreased (10 min and 30 min) at higher 
pSTAT3 CV values, and green bubble density (90 
min) increased at lower pSTAT3 CV values. 
Figure 6. CV was significantly correlated to %change of 
MFI, but not MFI.
The CV was obtained from the results of Figure 4. Left-
hand side panels show the results of IFN-α treatment, 
and right-hand side panels show the results of IL-21 
treatment. The correlation between CV and %change of 
MFI (upper panels) and between CV and MFI (lower 
panels) are plotted with the Pearson R value. Asterisks 
denote significant correlation (**, P < 0.01; ***, P < 
0.001).
Figure 8. Down-regulation of pERK1/2 MFI and up-
regulation of ERK1/2 CV by low temperature and 
MEK1/2 inhibitor (U0126) treatment.
Jurkat cels were incubated at 37°C or 4°C for 10 min (A, 
B, and C). The cels were also treated with U0126 for 10 
min at 37°C (D, E, and F), and then MFI and CV of 
pERK were measured. Down-regulation of MFI is shown 
in (A) and (D), and up-regulation of CV is shown in (B) 
and (E). The correlations between CV and MFI are 
shown in (C) and (F). Statistical analysis was calculated 
with a paired t-test (A and B) and one-way ANOVA with 
Bonferroni’s post hoc test (D and E) (*, P < 0.05; ***, P 
< 0.001). Data are mean ± SE, n = 4.
Figure 7. Down-regulation of pERK1/2 MFI by IFN-α 
and IL-21 and the correlation between pERK MFI and 
pERK CV.
Jurkat cels were stimulated with IFN-α (100 U/mL) 
and IL-21 (1 nM) for 10 min. MFI and CV of pERK were 
measured. The correlations between CV and MFI are 
shown in (C). Comparison of vehicle to IFN-α or IL-21 
treatment was performed by one-way ANOVA with 
Bonferroni’s post hoc test (***, P < 0.001). Data are 
mean ± SE, n = 10.
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Subsequently, pSTAT1 CV also transitioned from 
fluctuation to contraction. The size of green bubbles 
(90 min) was larger than that of blue bubbles (0 min), 
and each bubble size was larger at lower pSTATs CV 
values compared to that at higher pSTATs CV values 
with IL-21 treatment. The positions of the blue 
bubbles (0 min) indicated by the blue dashed elipses 
were changed to the reduced positions of the green 
bubbles (90 min) shown by the green dashed elipses. 
The changing of bubble position on the CV-axes with 
bubble size related to CV of another signal transducer 
may help visualization of contractive and fluctuating 
signals.
Categorization of signal transducers by combination of 
MFI and CV
　In a heterogeneous cel population, the determina-
tion of the activated signal transduction pathways is 
dificult, since the initial status of each cel is not 
same. However, heterogeneity is universal. In this 
study, lymphocytes, which were not divided into B 
cels or T cels, were used for analysis of signal 
pathways with CV and MFI. In spite of that, the 
signal pathways in lymphocytes could be categorized 
by a combination of MFI and CV (Table 2 and Fig. 
10). We categorized signals into three classes 
(contractive signals, fluctuating signals, and passive 
signals) by CV because the contraction is considered 
related to observable action in the upper layer (Fig. 
1). The contractive signals were further separated 
into two categories, attractive signals and negative 
arbiter signals, based on increase and decrease of 
MFI, respectively. The fluctuating signals were also 
separated into two categories, subsequent signals and 
counter signals, based on increase and decrease of 
MFI, respectively. The third category was passive 
signals, which do not induce a clear change in both 
CV and MFI. The categorization was consistent with 
the previous observations of signal transduction 
activated by IL-21, and could explain the function of 
IL-21 on lymphocytes14), 26), 27), i.e., IL-21 mainly 
activates STAT3 in various lymphocytes, and 
alternatively activated STAT1 and STAT3 depend on 
lymphocyte type. These results suggested that it is 
possible to analyze the signals not only under ideal 
Table 2. Categorization of signal transducer status and 
function
Figure 9. Bubble chart analysis of time course and 
pERK1/2 fluctuation plotted on pSTATs axes.
Bubble chart graphs were drawn with Graph-R software. 
Bubble color indicates time course: blue = 0 min; red = 
10 min; yelow = 30 min; green = 90 min. Bubble 
diameter represents the value of pERK1/2 CV. 
Combinations of x-axes and y-axes are as folows: upper 
panels = pSTAT1 CV (x) and pSTAT3 CV (y); middle 
panels = pSTAT1 CV (x) and pSTAT5 CV (y); lower 
panels = pSTAT3 CV (x) and pSTAT5 CV (y). The left-
hand side panels show results of stimulation with IFN-
α, and the right-hand side panels show results of 
stimulation with IL-21.
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conditions using the cel line but also with any gated 
cel population using heterogeneous peripheral blood 
cels.
　When neutrophils were stimulated with IL-21, the 
phosphorylation of STAT3 (MFI) was decreased, and 
the phosphorylation of other signal transducers was 
not induced 23). These responses are commonly 
considered to be due to non-responsive cels; however, 
MFI of p38 MAPK and STAT1 were decreased, and 
CV of STAT1, STAT5, and ERK1/2 were increased 
(Fig. 11). These results suggested that neutrophils 
were responsive to IL-21, which induced negative 
arbiter signals and counter signals. Therefore, the 
categorization provides an opportunity for novel 
Figure 10. Categorization of signal transducers in 
lymphocytes by combination of MFI and CV.
Whole blood was stimulated with IL-21 (1 nM) for 10 
min. For the determination of basal status, whole blood 
was added to the vehicle diluents of IL-21 (PBS) and 
incubated for 10 min. These bloods were immediately 
fixed after the 10 min, and then phosphorylation of 
various signal transducers was measured as described in 
Materials and Methods. Lymphocytes were detected as 
myeloid linage marker (CD16 or CD11b) negative cels 
and SSClow populations. The kinetics of increase (plus) 
or decrease (minus) were calculated as folows: MFI 
kinetics (blue column) = (the value of MFI at 10 min 
treatment with IL-21) – (the value of MFI at 10 min 
treatment with PBS) or CV kinetics (red column) = (the 
value of CV at 10 min treatment with IL-21) – (the 
value of CV at 10 min treatment with PBS). The 
categorization of the signals was based on the data 
shown in Table 2. Total pY indicates total phosphotyro-
sine. Similarly, the name of each signal transducer is 
indicated above the respective panels. Data are mean ± 
SD (n = 3).
Figure 11. Categorization of signal transducers in 
neutrophils by combination of MFI and CV.
 Whole blood was stimulated with IL-21 (1 nM) for 10 
min. For the determination of basal status, whole blood 
was added to the vehicle diluents of IL-21 (PBS) and 
incubated for 10 min. These bloods were immediately 
fixed after the 10 min, and then phosphorylation of 
various signal transducers was measured as described in 
Materials and Methods. Neutrophils were gated by CD16 
(or CD11b) positive and SSChigh populations. The 
kinetics of increase (plus) or decrease (minus) were 
calculated as folows: MFI kinetics (blue column) = (the 
value of MFI at 10 min treatment with IL-21) –(the 
value of MFI at 10 min treatment with PBS) or CV 
kinetics (red column) = (the value of CV at 10 min 
treatment with IL-21) –(the value of CV at 10 min 
treatment with PBS). The categorization of the signals 
was based on the data shown in Table 2. Total pY 
indicates total phosphotyrosine. Similarly, the name of 
each signal transducer is indicated above the respective 
panels. Data are mean ± SD (n = 3).
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recognition of phenomena, functions, cel subsets, and 
molecular interactions.
Discussion
　Predicting the reaction cascade of enzymes in 
signal transduction pathways, which are hyper-
complex systems, is extremely dificult because the 
pathways are amplified and controled by various 
spatio-temporal mechanisms, such as cross-over 
interaction, feedback, or protein modifications, under 
heterogeneous conditions.
　In this study, we demonstrated that the CV of 
signal transducers indicated kinetics of signal 
pathways in the Jurkat cel line. The decrease of CV 
suggests a contraction of signal status, and the 
increase of CV indicates a fluctuation of signal status. 
In heterogeneous conditions (whole blood), the CV 
decrease was closely related with observable action. 
Furthermore, the combination of MFI and CV 
provides a novel categorization of signal pathways as 
folows: contractive signals (consisting of attractive 
signals and negative arbiter signals), fluctuating 
signals (consisting of subsequent signals and counter 
signals), and passive signals.
　Neutrophils are not a simple population. Five 
subsets were detected in a mouse neutrophil 
population by a 38-antibody panel using mass 
cytometry 28). However, there are limits in detection of 
minute diferences among surface antigens because 
neutrophil surface antigens vary with methods of 
neutrophil separation or the process of neutrophil 
maturation 23), 29). Instead of high-dimensional surface 
analysis data, the dispersion information is one of the 
markers for functional cel clusters in heterogeneous 
cels29). These previous observations indicate that the 
categorization is useful to characterize signal 
pathways in these heterogeneous cel clusters.
　Many reports show eficacy of IL-21 for cancer 
treatment30)－33). Recently, combined IL-21-primed 
polyclonal CTL plus CTLA4 blockade controled 
refractory metastatic melanoma34). The combination 
of IL-21 with IFN-α boosts STAT3 activation, 
cytotoxicity, and experimental tumor therapy15). It is 
expected that the combined treatment of cytokines 
and immune checkpoint inhibitors wil become more 
common. The categorization of signals may be more 
useful for prediction of combined stimulations, such 
as drug or cytokine combinations, on heterogeneous 
blood samples. 
　We observed the counter signals belonging to the 
fluctuating signals. Observable action implies robust 
attraction among other signals. We speculate that the 
counter signals may maintain dynamic equilibrium as 
folows: Negative arbiter signals (a0) and attractive 
signals (a1) are important for action, but are risk 
factors for homeostasis. The subsequent signals (a2) 
are candidates for the next attractions; thus, the 
number of attraction signals (a = a0 + a1 + a2) should 
be lower than the number of counter signals (c), i.e., 
homeostasis is a < c, and prolapse of homeostasis is 
a > c. In Jurkat cels, ERK1/2 pathway is considered a 
counter signal during stimulation with IL-21 or low 
temperature. The investigation of counter signals 
may open a new avenue to analyze dynamic 
equilibrium.
　In this study, we proposed novel recognition 
methods of signal pathways using flow cytometry. The 
contraction and fluctuation of cel clusters are useful 
to categorize the signal characteristics. We expect that 
this method can be applied to various molecule 
statuses and evolve into an efective technique to 
replace high-dimensional analysis.
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